Impact of antimicrobial stewardship programme on carbapenem resistance in gram negative isolates in an Indian tertiary care hospital

American Journal of Infectious Diseases

Volumn 8, Issue 2, 2012, Pages 106-111

  Jaggi, Namita ^a   Sissodia, Pushpa ^a   Sharma, Lalit ^a  

^a ARTEMIS HOSPITAL   (India)

Author keywords

Antimicrobial stewardship program; Carbapenem resistance; Gram negatives

Indexed keywords

CARBAPENEM;

ACINETOBACTER INFECTION; ANTIBIOTIC RESISTANCE; ARTICLE; BLOOD CULTURE; DRUG SENSITIVITY; ESCHERICHIA COLI INFECTION; HEALTH CARE COST; HEALTH CARE PLANNING; HEALTH PROGRAM; INTERVENTION STUDY; KLEBSIELLA INFECTION; NONHUMAN; PRACTICE GUIDELINE; PSEUDOMONAS INFECTION; RETROSPECTIVE STUDY; TERTIARY HEALTH CARE; URINE CULTURE;

EID: 84875385349     PISSN: 15536203     EISSN: None     Source Type: Journal    
DOI: 10.3844/ajidsp.2012.106.111     Document Type: Article

References (24)

1. Baumgart, A.M., M.A. Molinari and A.C. Silveira, 2010. Prevalence of carbapenem resistant Pseudomonas aeruginosa and Acinetobacter baumannii in high complexity hospital. Braz. J. Infect. Dis., 14: 433-436. PMID: 21221469
2. Brown, E.M. and D. Nathwani, 2005. Antibiotic cycling or rotation: A systematic review of the evidence of efficacy. J. Antimicrob. Chemother., 55: 6-9. DOI: 10.1093/jac/dkh482
3. CLSI, 2007. Performance standards for antimicrobial susceptibility testing; seventeenth informational supplement. Clinical and Laboratory Standards Institute, Wayne, PA.
4. CLSI, 2009. Performance standards for antimicrobial susceptibility testing; nineteenth informational supplement. Clinical and Laboratory Standards Institute, Wayne, PA.
5. CLSI, 2011. Performance standards for antimicrobial susceptibility testing; twenty-first informational supplement. Clinical and Laboratory Standards Institute, Wayne, PA.
6. DH, 2000. UK antimicrobial resistance strategy and action plan. Department of Health.
7. Fishman, N., 2006. Antimicrobial stewardship. Am. J. Med., 119: S53-S61. PMID: 16735152
8. Forster, D.H. and F.D. Daschner, 1998. Acinetobacter Species as Nosocomial Pathogens. Eur. J. Clin. Microbiol Infect. Dis., 17: 73-77.
9. GARP, 2011. Rationalizing antibiotic use to limit antibiotic resistance in India. Indian J. Med. Res., 134: 281-294.
10. Gonlugur, U., M.Z. Bakici, I. Akkurt and T. Efeoglu, 2004. Antibiotic susceptibility patterns among respiratory isolates of Gram-negative bacilli in a Turkish university hospital. BMC Microbiol., 4: 32-32. DOI: 10.1186/1471-2180-4-32
11. Hancock, R.E., 1998. Resistance mechanisms in Pseudomonas aeruginosa and other nonfermentative gram-negative bacteria. Clin. Infect. Dis., 27: S93-S99. PMID: 9710677
12. Livermore, D.M., 1998. Beta-lactamase-mediated resistance and opportunities for its control. J. Antimicrob. Chemother., 41: 25-41. DOI: 10.1093/jac/41.suppl_4.25
13. MacDougall, C. and R.E. Polk, 2005. Antimicrobial stewardship programs in health care systems. Clin. Micro. Rev., 18: 638-656. DOI: 10.1128/CMR.18.4.638-656.2005
14. Mathur, P., A. Kapil, B. Das and B. Dhawan, 2002. Prevalence of extended spectrum beta lactamase producing gram negative bacteria in a tertiary care hospital. Indian J. Med. Res., 115: 153-157. PMID: 12239838
15. Muto, C.A., M.K. Blank, J.W. Marsh, E.N. Vergis and M.M. O'Leary et al., 2007. Control of an outbreak of infection with the hypervirulent Clostridium difficile BI strain in a university hospital using a comprehensive "bundle" approach. Clin. Infect. Dis., 45: 1266-1273. PMID: 17968819
16. Navaneeth, B.V., D. Sridaran, D. Sahay and M.R.S. Belwadi, 2002. A preliminary study on metallo b- lactamase producing Pseudomonas spp. aeruginosa in hospitalized patients. Indian J. Med. Res., 116: 264-267.
17. Nordmann, P. and L. Poirel, 2002. Emerging carbapenemases in Gram-negative aerobes. Clin. Microbiol. Infect., 8: 321-331. DOI:
18. O'Brien, T.F., 1997. The global epidemic nature of antimicrobial resistance and the need to monitor and manage it locally. Clin. Infect. Dis., 24: S2-S8. PMID: 8994775
19. O'Brien, T.F., 2002. Emergence, spread and environmental effect of antimicrobial resistance: how use of an antimicrobial anywhere can increase resistance to any antimicrobial anywhere else. Clin. Infect. Dis., 34: S78-S84. DOI: 10.1086/340244
20. Oliver, A., 2004. Resistencia a carbapenemas y Acinetobacter baumannii. Enferm. Infec. Microbiol. Clin., 22: 259-261.
21. Patel, D., W. Lawson and B.J. Guglielmo, 2008. Antimicrobial stewardship programs: Interventions and associated outcomes. Expert Rev. Anti. Infect. Ther., 6: 209-222. DOI: 10.1586/14787210.6.2.209
22. Paterson, D.L., 2006. Resistance in gram-negative bacteria: Enterobacteriaceae. Am. J. Med., 119: S20-S28. PMID: 16735147
23. Poirel, L. and P. Nordmann, 2006. Carbapenem resistance in Acinetobacter baumannii: Mechanisms and epidemiology. Clin. Microbiol. Infect., 12: 826-836. DOI: 10.1111/j.1469- 0691.2006.01456.x
24. WHO, 2001. WHO global strategy for containment of antimicrobial resistance. World Health Organization, Geneva, Switzerland.